BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Nov. 8, 2018

View Archived Issues

FDA gives nod to Maxq AI's hemorrhage-detection software

Maxq AI Ltd.'s Accipio Ix intracranial hemorrhage (ICH) detection software scored U.S. FDA clearance. It aims to help in prioritizing the clinical assessment of adult noncontrast head computed tomography (CT) cases that exhibit indications of ICH, or brain bleed, resulting from stroke or trauma. Read More

Mimedx to delist, fails to issue SEC reports amidst ongoing fallout from DoJ sales probe

Read More

Lucence's breast cancer test seeks to avoid removing healthy tissue

Read More

Growing connections between vascular system and dementia

Read More

Other news to note

Read More

Financings

Read More

Daily M&A

Read More

Appointments and advancements

Read More

Product briefs

Read More

BioWorld MedTech's Orthopedics Extra

Read More

Federal government appears ready to sustain deregulatory effort in 2019

The U.S. mid-term elections are over and the 116th Congress will be sworn in to start the new year, but the changing of the guard in the House of Representatives is likely to ramp up the scrutiny on drugmakers, particularly on the question of pricing. In contrast, the impact of the Democratic Party's takeover of the House of Representatives on the regulation of drugs, devices and diagnostics may prove negligible, suggesting that federal government agencies will sustain the associated deregulatory effort that commenced in January 2017. Read More

U.S. midterm results not the worst-case scenario for biotech

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing